PAB 3.70% 2.6¢ patrys limited

Company to resolve

  1. 595 Posts.
    As a result it is unlikely that the next clinical trial will commence in the second quarter as planned. Patrys is working to have the issues resolved quickly, but until further investigation is complete it cannot make a definitive statement as to the exact timing of the commencement of its next trial. While this delay is extremely disappointing these events are not uncommon in the manufacturing of biologicals.
    Come on people the company states it's next trial will be soon, not all is lost .
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Mkt cap $27.83M
Open High Low Value Volume
2.7¢ 2.8¢ 2.5¢ $19.45K 749.4K

Buyers (Bids)

No. Vol. Price($)
5 1773152 2.5¢

Sellers (Offers)

Price($) Vol. No.
2.6¢ 102819 2
Last update - 16.10pm 14/12/2018 (20 minute delay) ?
-0.00 ( 3.85 %)
Open High   Low Volume
2.7¢ 2.7¢   2.5¢ 246939
Last updated 15.16pm 14/12/2018 (live) ?
PAB (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.